Marco Pravetoni, Ph.D.
Affiliations: | 2008 | University of Minnesota, Twin Cities, Minneapolis, MN |
Area:
PharmacologyGoogle:
"Marco Pravetoni"Mean distance: 23748
Parents
Sign in to add mentor| Kevin Wickman | grad student | 2008 | UMN | |
| (Role of G protein gated potassium channels in centrally-mediated and drug -induced behaviors.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Powers N, Massena C, Crouse B, et al. (2023) Self-Adjuvanting TLR7/8 Agonist and Fentanyl Hapten Co-Conjugate Achieves Enhanced Protection against Fentanyl Challenge. Bioconjugate Chemistry. 34: 1811-1821 |
| Crouse B, Miller SM, Muelken P, et al. (2023) A TLR7/8 agonist increases efficacy of anti-fentanyl vaccines in rodent and porcine models. Npj Vaccines. 8: 107 |
| Miller SM, Crouse B, Hicks L, et al. (2023) A lipidated TLR7/8 adjuvant enhances the efficacy of a vaccine against fentanyl in mice. Npj Vaccines. 8: 97 |
| Martinez S, Harris H, Chao T, et al. (2023) The potential role of opioid vaccines and monoclonal antibodies in the opioid overdose crisis. Expert Opinion On Investigational Drugs. 1-5 |
| Triller G, Vlachou EP, Hashemi H, et al. (2023) A trypanosome-derived immunotherapeutics platform elicits potent high-affinity antibodies, negating the effects of the synthetic opioid fentanyl. Cell Reports. 42: 112049 |
| Crouse B, Wu MM, Gradinati V, et al. (2022) Efficacy and Selectivity of Monovalent and Bivalent Vaccination Strategies to Protect against Exposure to Carfentanil, Fentanyl, and Their Mixtures in Rats. Acs Pharmacology & Translational Science. 5: 331-343 |
| Hamid FA, Marker CL, Raleigh MD, et al. (2022) Pre-clinical safety and toxicology profile of a candidate vaccine to treat oxycodone use disorder. Vaccine. 40: 3244-3252 |
| Baehr CA, Wu MM, Pandit SG, et al. (2022) . The Journal of Pharmacology and Experimental Therapeutics |
| Crouse B, Zhang L, Robinson C, et al. (2021) Housing conditions and microbial environment do not affect the efficacy of vaccines for treatment of opioid use disorders in mice and rats. Human Vaccines & Immunotherapeutics. 1-10 |
| Huseby Kelcher AM, Baehr CA, Hamid FA, et al. (2021) Contribution of Antibody-Mediated Effector Functions to the Mechanism of Efficacy of Vaccines for Opioid Use Disorders. Journal of Immunology (Baltimore, Md. : 1950) |